NCT02352116 Evaluation of Post-PACU Pain Management in Pediatric Surgery
| NCT ID | NCT02352116 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Columbia University |
| Condition | Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 900 participants |
| Start Date | 2013-06 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 900 participants in total. It began in 2013-06 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to assess the differences in overall pain severity, pain management, and satisfaction during recovery period between two groups of children who either receive or do not receive additional education related to expectation and management of postoperative pain.
Eligibility Criteria
Inclusion Criteria: * Patients ages 1-6 years undergoing ambulatory surgical procedures. * Patients with an ASA status of I or II spending 23 hours or less recovering in the PACU and discharged home. Exclusion Criteria: * Patients with an ASA status of III or IV. * Patients admitted as inpatients or transferred to the PICU or inpatient for recovery, and any conditions that may affect pain expression or sensation.
Contact & Investigator
Lena S. Sun, MD
📞 212-305-2413
Lena S. Sun, MD
PRINCIPAL INVESTIGATOR
Columbia University
Frequently Asked Questions
Who can join the NCT02352116 clinical trial?
This trial is open to participants of all sexes, aged 1 Year or older, up to 6 Years, studying Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02352116 currently recruiting?
Yes, NCT02352116 is actively recruiting participants. Visit ClinicalTrials.gov or contact Columbia University to inquire about joining.
Where is the NCT02352116 trial being conducted?
This trial is being conducted at New York, United States.
Who is sponsoring the NCT02352116 clinical trial?
NCT02352116 is sponsored by Columbia University. The principal investigator is Lena S. Sun, MD at Columbia University. The trial plans to enroll 900 participants.